Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2006, Vol. 11 ›› Issue (8): 847-850.

Previous Articles     Next Articles

Advances in preclinical studies on combination therapy of myocardial ischemia

WANG Zhan-qing1,2, YING Xiang-yu2, XU Jing-feng1   

  1. 1General Hospital of Beijing Command of PLA, Beijing 100700 , China;
    2Institute of Pharmacology and Toxicology , Academy of Military Medical Sciences, Beijing 100850 , China
  • Received:2006-05-15 Revised:2006-07-04 Online:2006-08-26 Published:2020-11-05

Abstract: The combination therapy of anti-myocardial ischemia has advantages of not only augmenting the therapy and reducing dose of some drugs, but also enhancing the myocardial ischemia preconditioning, reducing the product which is of damage to the heart tissue and the body, preventing the ischemic arrhythmias, and augmenting the rebuilding of the heart tissue and vessel tissue.

Key words: myocardial ischemia, combination therapy, ischemia preconditioning, superoxide, ischemic arrhythmias, myocardial rebuilding

CLC Number: